SCHEMBL24310499

SCHEMBL24310499

[O-][S+](c1ccccc1)c1cc(-c2ccccc2)nc(NSc2ccccc2)n1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AGTR1 P30556 4/20 0.39
MAPT P10636 4/20 0.39
TDP1 Q9NUW8 1/20 0.39
ADORA1 P30542 8/20 0.35
ADORA3 P0DMS8 4/20 0.35
ABCB1 P08183 1/20 0.33
ABCC1 P33527 1/20 0.33
ABCG2 Q9UNQ0 1/20 0.33
ADORA2A P29274 3/20 0.33
GAA P10253 2/20 0.33
KDM4E B2RXH2 2/20 0.33
ADORA2B P29275 1/20 0.33
SMN1; SMN2 Q16637 2/20 0.32
CYP1A2 P05177 1/20 0.32
CYP3A4 P08684 1/20 0.32
CYP2C9 P11712 1/20 0.32
CYP2C19 P33261 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
MEN1 O00255 2/20 0.32
KMT2A Q03164 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11289134 0.81 AGTR1 (0.56) AGTR1MAPTTDP1ADORA1ADORA3
SCHEMBL24309613 0.76 MAPT (0.44) AGTR1MAPTTDP1ADORA1ADORA3
SCHEMBL24310308 0.75 KDM4E (0.50) AGTR1MAPTTDP1ADORA1ADORA3
SCHEMBL24310500 0.74 MAPT (0.61) MAPTGAAKDM4ESMN1; SMN2CYP1A2
SCHEMBL29567026 0.74 MAPT (0.61) MAPTGAAKDM4ESMN1; SMN2CYP1A2
SCHEMBL24309283 0.72 TDP1 (0.46) AGTR1MAPTTDP1ADORA1ADORA3
SCHEMBL24310313 0.72 SRC (0.30) AGTR1
SCHEMBL24309752 0.70 MAPK1 (0.57) AGTR1MAPTTDP1ADORA1ADORA3
SCHEMBL24309268 0.69 BPTF (0.44) AGTR1MAPTTDP1ADORA1ADORA3
SCHEMBL24310492 0.68 TDP1 (0.44) AGTR1MAPTTDP1ADORA1ADORA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022076627-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 WO disclosed